| 6.4 |
25.6 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 6.0 |
48.3 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 4.1 |
12.2 |
GO:0019413 |
acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
| 3.8 |
15.4 |
GO:1900228 |
biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 3.5 |
17.7 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 3.2 |
9.7 |
GO:1903567 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 3.2 |
104.2 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 2.9 |
8.7 |
GO:1903400 |
L-arginine transmembrane transport(GO:1903400) |
| 2.7 |
10.9 |
GO:0002399 |
MHC class II protein complex assembly(GO:0002399) |
| 2.6 |
2.6 |
GO:2000224 |
regulation of testosterone biosynthetic process(GO:2000224) |
| 2.6 |
7.7 |
GO:0070662 |
mast cell proliferation(GO:0070662) |
| 2.6 |
7.7 |
GO:0061713 |
neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 2.5 |
12.6 |
GO:2001107 |
negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
| 2.5 |
9.9 |
GO:0009447 |
putrescine catabolic process(GO:0009447) |
| 2.5 |
2.5 |
GO:2000847 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 2.5 |
7.4 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 2.4 |
17.1 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) |
| 2.4 |
7.1 |
GO:1904897 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 2.3 |
9.3 |
GO:0072134 |
nephrogenic mesenchyme morphogenesis(GO:0072134) |
| 2.3 |
6.9 |
GO:0061149 |
apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 2.2 |
6.6 |
GO:0021538 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 2.2 |
8.8 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 2.2 |
2.2 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 2.2 |
6.5 |
GO:0060003 |
copper ion export(GO:0060003) |
| 2.1 |
8.5 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 2.0 |
13.9 |
GO:0018406 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 2.0 |
2.0 |
GO:0048378 |
lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 1.9 |
5.8 |
GO:0002415 |
immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 1.9 |
3.7 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 1.9 |
3.7 |
GO:0002032 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 1.8 |
18.1 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 1.8 |
5.3 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 1.8 |
5.3 |
GO:0035691 |
macrophage migration inhibitory factor signaling pathway(GO:0035691) |
| 1.7 |
5.2 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 1.7 |
18.8 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
| 1.7 |
93.9 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 1.7 |
10.0 |
GO:0010731 |
protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 1.7 |
1.7 |
GO:1904882 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 1.6 |
4.9 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 1.6 |
6.6 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 1.6 |
4.9 |
GO:0034395 |
regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 1.6 |
6.5 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 1.6 |
24.0 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 1.6 |
4.8 |
GO:0051040 |
regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 1.6 |
9.6 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
| 1.6 |
3.2 |
GO:2000836 |
androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
| 1.6 |
6.3 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 1.5 |
34.1 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 1.5 |
10.7 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 1.5 |
24.3 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 1.5 |
6.0 |
GO:0010430 |
fatty acid omega-oxidation(GO:0010430) |
| 1.5 |
4.4 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 1.4 |
4.3 |
GO:0061571 |
dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 1.4 |
5.7 |
GO:0035283 |
central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 1.4 |
5.6 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.4 |
7.1 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 1.4 |
7.0 |
GO:1902998 |
regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 1.4 |
8.4 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 1.4 |
4.2 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 1.4 |
15.4 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 1.4 |
2.8 |
GO:1904845 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 1.4 |
1.4 |
GO:2000426 |
negative regulation of apoptotic cell clearance(GO:2000426) |
| 1.3 |
69.9 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 1.3 |
4.0 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 1.3 |
4.0 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 1.3 |
4.0 |
GO:1903892 |
negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
| 1.3 |
6.6 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 1.3 |
3.9 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 1.3 |
3.9 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 1.3 |
3.9 |
GO:0099552 |
trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 1.3 |
1.3 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 1.3 |
5.1 |
GO:0045917 |
positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 1.3 |
3.8 |
GO:0036304 |
umbilical cord morphogenesis(GO:0036304) umbilical cord development(GO:0061027) |
| 1.2 |
2.5 |
GO:0034769 |
basement membrane disassembly(GO:0034769) |
| 1.2 |
3.7 |
GO:0071931 |
positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) |
| 1.2 |
4.9 |
GO:1990166 |
protein localization to site of double-strand break(GO:1990166) |
| 1.2 |
12.2 |
GO:0071798 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 1.2 |
3.6 |
GO:2000078 |
positive regulation of type B pancreatic cell development(GO:2000078) |
| 1.2 |
3.6 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 1.2 |
4.8 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 1.2 |
7.1 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 1.2 |
11.8 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 1.2 |
2.3 |
GO:0036446 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 1.1 |
6.9 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 1.1 |
3.4 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 1.1 |
8.0 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 1.1 |
3.4 |
GO:0035638 |
patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
| 1.1 |
14.7 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 1.1 |
3.4 |
GO:0034414 |
tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) |
| 1.1 |
4.5 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 1.1 |
3.3 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 1.1 |
1.1 |
GO:0072081 |
intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
| 1.1 |
7.7 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 1.1 |
4.4 |
GO:1903173 |
phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 1.1 |
1.1 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 1.1 |
24.7 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 1.1 |
4.3 |
GO:1900827 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 1.1 |
3.2 |
GO:0072312 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 1.1 |
3.2 |
GO:0019303 |
D-ribose catabolic process(GO:0019303) |
| 1.1 |
10.6 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 1.1 |
8.5 |
GO:0006203 |
dGTP catabolic process(GO:0006203) |
| 1.0 |
3.1 |
GO:0046452 |
dihydrofolate metabolic process(GO:0046452) |
| 1.0 |
11.5 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 1.0 |
5.2 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 1.0 |
1.0 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 1.0 |
1.0 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 1.0 |
4.1 |
GO:0043060 |
meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
| 1.0 |
3.0 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 1.0 |
3.0 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 1.0 |
8.1 |
GO:0061709 |
reticulophagy(GO:0061709) |
| 1.0 |
3.0 |
GO:0035915 |
pore formation in membrane of other organism(GO:0035915) |
| 1.0 |
3.0 |
GO:0034031 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 1.0 |
3.0 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 1.0 |
6.0 |
GO:0044336 |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 1.0 |
7.0 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 1.0 |
2.0 |
GO:0060434 |
bronchus morphogenesis(GO:0060434) |
| 1.0 |
7.8 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 1.0 |
4.9 |
GO:1901090 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 1.0 |
4.9 |
GO:1902361 |
mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 1.0 |
1.0 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 1.0 |
2.9 |
GO:1904017 |
cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 1.0 |
1.0 |
GO:0002071 |
glandular epithelial cell maturation(GO:0002071) |
| 1.0 |
10.6 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 1.0 |
3.8 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 1.0 |
2.9 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 1.0 |
3.8 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 1.0 |
2.9 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 1.0 |
7.6 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 1.0 |
1.0 |
GO:1902232 |
regulation of positive thymic T cell selection(GO:1902232) |
| 0.9 |
0.9 |
GO:1902732 |
positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.9 |
2.8 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.9 |
11.3 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.9 |
2.8 |
GO:0006393 |
termination of mitochondrial transcription(GO:0006393) |
| 0.9 |
3.7 |
GO:0006740 |
NADPH regeneration(GO:0006740) |
| 0.9 |
6.5 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.9 |
0.9 |
GO:2000619 |
negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.9 |
2.8 |
GO:1903949 |
positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.9 |
2.8 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.9 |
2.7 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.9 |
9.1 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.9 |
10.1 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.9 |
0.9 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.9 |
2.7 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.9 |
3.6 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.9 |
3.6 |
GO:1903786 |
mycotoxin metabolic process(GO:0043385) mycotoxin catabolic process(GO:0043387) aflatoxin metabolic process(GO:0046222) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound metabolic process(GO:1901376) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.9 |
6.3 |
GO:0044782 |
cilium organization(GO:0044782) |
| 0.9 |
6.2 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.9 |
2.6 |
GO:0006147 |
guanine catabolic process(GO:0006147) |
| 0.9 |
7.9 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.9 |
1.8 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.9 |
2.6 |
GO:0051596 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.9 |
2.6 |
GO:1900920 |
regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 0.9 |
0.9 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.9 |
2.6 |
GO:0019521 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.9 |
4.3 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.9 |
4.3 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.9 |
5.1 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.8 |
3.4 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.8 |
5.1 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.8 |
7.6 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.8 |
1.7 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.8 |
2.5 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.8 |
2.5 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.8 |
5.8 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.8 |
3.3 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.8 |
2.5 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.8 |
3.3 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.8 |
5.7 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.8 |
2.4 |
GO:1903937 |
response to acrylamide(GO:1903937) |
| 0.8 |
4.9 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.8 |
4.0 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.8 |
2.4 |
GO:0097156 |
fasciculation of motor neuron axon(GO:0097156) |
| 0.8 |
4.0 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.8 |
0.8 |
GO:0030581 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.8 |
7.3 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.8 |
4.8 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.8 |
0.8 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.8 |
0.8 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.8 |
13.6 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.8 |
3.2 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.8 |
2.4 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.8 |
7.9 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.8 |
12.7 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.8 |
0.8 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.8 |
10.3 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.8 |
8.5 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.8 |
3.1 |
GO:0005985 |
sucrose metabolic process(GO:0005985) sucrose biosynthetic process(GO:0005986) |
| 0.8 |
23.1 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.8 |
6.1 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.8 |
9.1 |
GO:0021694 |
cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.8 |
9.1 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.8 |
0.8 |
GO:0097252 |
oligodendrocyte apoptotic process(GO:0097252) |
| 0.8 |
10.5 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.8 |
3.0 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.8 |
1.5 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.8 |
3.0 |
GO:0021827 |
cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 0.7 |
1.5 |
GO:0031393 |
negative regulation of prostaglandin biosynthetic process(GO:0031393) |
| 0.7 |
2.2 |
GO:0014813 |
skeletal muscle satellite cell commitment(GO:0014813) |
| 0.7 |
3.0 |
GO:0090156 |
cellular sphingolipid homeostasis(GO:0090156) |
| 0.7 |
5.2 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.7 |
7.4 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.7 |
0.7 |
GO:0072194 |
kidney smooth muscle tissue development(GO:0072194) |
| 0.7 |
2.9 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.7 |
8.7 |
GO:0021853 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.7 |
2.2 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.7 |
3.6 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.7 |
1.4 |
GO:0030185 |
nitric oxide transport(GO:0030185) |
| 0.7 |
0.7 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.7 |
3.6 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.7 |
2.1 |
GO:0048880 |
sensory system development(GO:0048880) |
| 0.7 |
5.0 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.7 |
10.7 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.7 |
2.8 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.7 |
2.8 |
GO:0042091 |
interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 0.7 |
3.5 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.7 |
4.9 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.7 |
2.1 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.7 |
3.5 |
GO:0033387 |
putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.7 |
2.8 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
| 0.7 |
4.2 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.7 |
0.7 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.7 |
2.1 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.7 |
0.7 |
GO:1990164 |
histone H2A phosphorylation(GO:1990164) |
| 0.7 |
2.1 |
GO:1902524 |
positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 0.7 |
14.5 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.7 |
2.1 |
GO:0006678 |
glucosylceramide metabolic process(GO:0006678) |
| 0.7 |
5.5 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 0.7 |
4.1 |
GO:0035404 |
histone-serine phosphorylation(GO:0035404) |
| 0.7 |
2.7 |
GO:0031548 |
regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.7 |
2.0 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.7 |
1.4 |
GO:0006864 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.7 |
4.7 |
GO:0033504 |
floor plate development(GO:0033504) |
| 0.7 |
4.7 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.7 |
8.7 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.7 |
2.7 |
GO:1904800 |
negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.7 |
18.1 |
GO:1901663 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.7 |
10.7 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.7 |
4.0 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.7 |
0.7 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.7 |
4.0 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.7 |
5.9 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.7 |
21.7 |
GO:0015991 |
ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.6 |
4.5 |
GO:0015677 |
copper ion import(GO:0015677) |
| 0.6 |
8.4 |
GO:0090240 |
positive regulation of histone H4 acetylation(GO:0090240) |
| 0.6 |
1.9 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.6 |
3.9 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.6 |
3.2 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.6 |
1.3 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.6 |
13.4 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.6 |
5.1 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.6 |
5.7 |
GO:0097499 |
protein localization to nonmotile primary cilium(GO:0097499) |
| 0.6 |
5.1 |
GO:1990822 |
basic amino acid transmembrane transport(GO:1990822) |
| 0.6 |
1.9 |
GO:0038178 |
complement component C5a signaling pathway(GO:0038178) |
| 0.6 |
3.2 |
GO:0034486 |
vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) |
| 0.6 |
0.6 |
GO:2000322 |
regulation of glucocorticoid receptor signaling pathway(GO:2000322) negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.6 |
2.5 |
GO:0070426 |
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.6 |
2.5 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.6 |
1.3 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.6 |
8.8 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.6 |
10.0 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.6 |
1.2 |
GO:0060151 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.6 |
4.4 |
GO:1902731 |
negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.6 |
10.5 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.6 |
2.5 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.6 |
1.8 |
GO:0061026 |
cardiac muscle tissue regeneration(GO:0061026) |
| 0.6 |
2.4 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.6 |
1.2 |
GO:0097267 |
omega-hydroxylase P450 pathway(GO:0097267) |
| 0.6 |
3.6 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.6 |
1.8 |
GO:0002752 |
cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.6 |
1.8 |
GO:1901253 |
negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.6 |
1.2 |
GO:0046984 |
regulation of hemoglobin biosynthetic process(GO:0046984) |
| 0.6 |
0.6 |
GO:1903422 |
negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.6 |
5.4 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 0.6 |
1.8 |
GO:0003011 |
involuntary skeletal muscle contraction(GO:0003011) |
| 0.6 |
1.8 |
GO:0019483 |
beta-alanine biosynthetic process(GO:0019483) |
| 0.6 |
3.0 |
GO:0014038 |
regulation of Schwann cell differentiation(GO:0014038) |
| 0.6 |
1.8 |
GO:0034402 |
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.6 |
1.8 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.6 |
4.1 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.6 |
11.2 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.6 |
0.6 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.6 |
3.5 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.6 |
2.9 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.6 |
2.9 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.6 |
1.2 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.6 |
1.7 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.6 |
1.7 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.6 |
5.8 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.6 |
1.7 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.6 |
0.6 |
GO:0071284 |
cellular response to lead ion(GO:0071284) |
| 0.6 |
2.3 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.6 |
1.1 |
GO:0035740 |
CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.6 |
1.7 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.6 |
13.6 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.6 |
2.3 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.6 |
2.3 |
GO:0050823 |
peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.6 |
2.3 |
GO:0018032 |
protein amidation(GO:0018032) |
| 0.6 |
1.7 |
GO:0006683 |
galactosylceramide catabolic process(GO:0006683) |
| 0.6 |
2.3 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.6 |
2.8 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.6 |
1.1 |
GO:0060139 |
positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.6 |
2.8 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.6 |
1.7 |
GO:0061699 |
protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
| 0.6 |
11.7 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.6 |
1.1 |
GO:0051097 |
negative regulation of helicase activity(GO:0051097) |
| 0.6 |
1.7 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.6 |
2.2 |
GO:0097112 |
gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.5 |
0.5 |
GO:2000729 |
positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
| 0.5 |
2.2 |
GO:0030961 |
peptidyl-arginine hydroxylation(GO:0030961) |
| 0.5 |
2.7 |
GO:0061083 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.5 |
1.1 |
GO:0072143 |
mesangial cell development(GO:0072143) |
| 0.5 |
1.6 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.5 |
2.7 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.5 |
2.2 |
GO:1990637 |
response to prolactin(GO:1990637) |
| 0.5 |
1.6 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.5 |
9.1 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) |
| 0.5 |
2.7 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.5 |
0.5 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.5 |
4.8 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.5 |
9.0 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.5 |
1.1 |
GO:0070627 |
ferrous iron import(GO:0070627) |
| 0.5 |
3.2 |
GO:2000582 |
regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.5 |
3.2 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.5 |
1.1 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.5 |
7.3 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.5 |
1.6 |
GO:1905053 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.5 |
2.1 |
GO:0090301 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.5 |
5.2 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.5 |
2.1 |
GO:0060734 |
regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.5 |
3.1 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.5 |
2.6 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.5 |
1.5 |
GO:1902530 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.5 |
1.5 |
GO:0045629 |
negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.5 |
1.0 |
GO:0010446 |
response to alkaline pH(GO:0010446) |
| 0.5 |
3.0 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.5 |
3.5 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.5 |
3.0 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.5 |
1.5 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.5 |
2.0 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.5 |
6.5 |
GO:0043570 |
maintenance of DNA repeat elements(GO:0043570) |
| 0.5 |
4.0 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.5 |
1.5 |
GO:0050720 |
interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.5 |
1.5 |
GO:0035470 |
positive regulation of vascular wound healing(GO:0035470) |
| 0.5 |
1.5 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.5 |
3.0 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.5 |
0.5 |
GO:0052572 |
response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
| 0.5 |
1.5 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.5 |
5.4 |
GO:0042983 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.5 |
2.5 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.5 |
1.5 |
GO:0010931 |
macrophage tolerance induction(GO:0010931) regulation of macrophage tolerance induction(GO:0010932) positive regulation of macrophage tolerance induction(GO:0010933) |
| 0.5 |
2.5 |
GO:0046167 |
glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.5 |
1.5 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.5 |
1.5 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.5 |
3.4 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.5 |
0.5 |
GO:0070432 |
regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
| 0.5 |
1.0 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.5 |
1.5 |
GO:0032764 |
negative regulation of mast cell cytokine production(GO:0032764) |
| 0.5 |
1.5 |
GO:1902159 |
regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.5 |
4.9 |
GO:2000425 |
regulation of apoptotic cell clearance(GO:2000425) |
| 0.5 |
4.4 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 0.5 |
0.5 |
GO:0097694 |
establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
| 0.5 |
1.4 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.5 |
1.9 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.5 |
1.4 |
GO:0060309 |
elastin catabolic process(GO:0060309) |
| 0.5 |
1.4 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.5 |
2.4 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.5 |
0.5 |
GO:0006267 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.5 |
3.8 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.5 |
4.8 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.5 |
3.8 |
GO:0006335 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.5 |
2.4 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.5 |
0.9 |
GO:0060448 |
dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.5 |
1.9 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.5 |
7.5 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.5 |
6.1 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.5 |
1.9 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.5 |
6.1 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.5 |
4.2 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.5 |
1.9 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.5 |
2.3 |
GO:0048104 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.5 |
0.5 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.5 |
0.9 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.5 |
2.3 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.5 |
1.9 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.5 |
1.4 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.5 |
1.4 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
| 0.5 |
1.4 |
GO:0015785 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.5 |
1.4 |
GO:2000374 |
regulation of oxygen metabolic process(GO:2000374) |
| 0.5 |
1.4 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.5 |
2.8 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.5 |
2.3 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.5 |
3.6 |
GO:0060831 |
smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
| 0.5 |
2.3 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.5 |
3.2 |
GO:0072502 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.5 |
1.4 |
GO:1900127 |
positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.5 |
0.9 |
GO:0002351 |
serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.5 |
1.8 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 0.5 |
0.5 |
GO:1903891 |
regulation of ATF6-mediated unfolded protein response(GO:1903891) |
| 0.5 |
1.4 |
GO:0045829 |
negative regulation of isotype switching(GO:0045829) |
| 0.5 |
2.3 |
GO:0071025 |
RNA surveillance(GO:0071025) |
| 0.5 |
1.8 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.5 |
5.0 |
GO:0048302 |
regulation of isotype switching to IgG isotypes(GO:0048302) |
| 0.4 |
2.7 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.4 |
5.3 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.4 |
0.9 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.4 |
0.4 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.4 |
9.3 |
GO:0097034 |
mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.4 |
1.3 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.4 |
1.3 |
GO:0033386 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.4 |
0.9 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.4 |
4.3 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.4 |
0.4 |
GO:0051877 |
pigment granule aggregation in cell center(GO:0051877) |
| 0.4 |
1.3 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.4 |
1.3 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.4 |
2.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.4 |
3.0 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.4 |
1.7 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.4 |
31.4 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.4 |
2.1 |
GO:0009213 |
pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.4 |
0.8 |
GO:1903061 |
positive regulation of protein lipidation(GO:1903061) |
| 0.4 |
5.1 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.4 |
2.5 |
GO:1903751 |
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.4 |
1.7 |
GO:1901895 |
negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.4 |
0.8 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.4 |
3.4 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.4 |
2.5 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.4 |
7.5 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.4 |
2.5 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.4 |
1.2 |
GO:0098937 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.4 |
3.3 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.4 |
0.8 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.4 |
1.7 |
GO:1901318 |
negative regulation of sperm motility(GO:1901318) |
| 0.4 |
1.2 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.4 |
20.7 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.4 |
1.2 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.4 |
1.2 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.4 |
7.8 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.4 |
8.7 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.4 |
0.4 |
GO:2000397 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.4 |
1.6 |
GO:1904980 |
positive regulation of endosome organization(GO:1904980) |
| 0.4 |
1.2 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.4 |
0.8 |
GO:1905075 |
occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.4 |
28.6 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.4 |
1.2 |
GO:0021997 |
neural plate axis specification(GO:0021997) |
| 0.4 |
2.0 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 0.4 |
1.2 |
GO:0001555 |
oocyte growth(GO:0001555) |
| 0.4 |
1.6 |
GO:0032690 |
negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.4 |
7.7 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) |
| 0.4 |
1.6 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.4 |
4.1 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.4 |
0.4 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.4 |
0.8 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.4 |
1.2 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.4 |
0.8 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.4 |
1.6 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.4 |
4.0 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 0.4 |
0.8 |
GO:0003350 |
pulmonary myocardium development(GO:0003350) |
| 0.4 |
2.4 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.4 |
0.4 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.4 |
3.9 |
GO:0006273 |
lagging strand elongation(GO:0006273) |
| 0.4 |
3.2 |
GO:0001554 |
luteolysis(GO:0001554) |
| 0.4 |
12.6 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.4 |
3.9 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.4 |
0.4 |
GO:0018312 |
peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.4 |
3.1 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.4 |
1.2 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.4 |
3.1 |
GO:0097577 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.4 |
0.8 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.4 |
2.7 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.4 |
1.2 |
GO:0051595 |
response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.4 |
1.2 |
GO:0021530 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.4 |
6.5 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.4 |
1.1 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 0.4 |
2.7 |
GO:0032226 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.4 |
1.1 |
GO:0010909 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.4 |
3.0 |
GO:0098909 |
regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.4 |
3.0 |
GO:0051415 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.4 |
0.4 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.4 |
8.0 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.4 |
2.3 |
GO:2000234 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.4 |
1.9 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.4 |
0.8 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.4 |
1.5 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.4 |
3.8 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.4 |
1.5 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.4 |
0.4 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.4 |
1.5 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.4 |
0.7 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.4 |
0.7 |
GO:0097360 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.4 |
0.7 |
GO:2000583 |
regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.4 |
0.7 |
GO:0006114 |
glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.4 |
1.1 |
GO:0097056 |
selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.4 |
0.7 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.4 |
1.1 |
GO:0007057 |
spindle assembly involved in female meiosis I(GO:0007057) |
| 0.4 |
0.4 |
GO:0036005 |
response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.4 |
0.7 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.4 |
1.1 |
GO:0051228 |
mitotic spindle disassembly(GO:0051228) spindle disassembly(GO:0051230) |
| 0.4 |
5.1 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.4 |
1.8 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.4 |
3.6 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.4 |
2.5 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.4 |
1.4 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.4 |
1.1 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.4 |
0.4 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.4 |
2.1 |
GO:1903679 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.4 |
1.1 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.4 |
0.4 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.4 |
0.4 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.4 |
1.8 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.4 |
4.3 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.4 |
1.1 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.4 |
1.1 |
GO:0036245 |
cellular response to menadione(GO:0036245) |
| 0.4 |
0.4 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.4 |
1.4 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.4 |
1.8 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.3 |
1.0 |
GO:0006781 |
succinyl-CoA pathway(GO:0006781) |
| 0.3 |
8.7 |
GO:0097502 |
mannosylation(GO:0097502) |
| 0.3 |
1.0 |
GO:0019640 |
glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.3 |
19.5 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.3 |
1.0 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.3 |
2.1 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.3 |
1.4 |
GO:0001507 |
acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.3 |
1.0 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.3 |
4.1 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.3 |
1.0 |
GO:0070602 |
regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.3 |
0.7 |
GO:0071338 |
submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.3 |
0.3 |
GO:1902804 |
negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.3 |
5.1 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.3 |
2.0 |
GO:0033277 |
abortive mitotic cell cycle(GO:0033277) |
| 0.3 |
1.4 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.3 |
8.1 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.3 |
1.7 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.3 |
0.7 |
GO:0072708 |
response to sorbitol(GO:0072708) |
| 0.3 |
1.7 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.3 |
1.0 |
GO:0071140 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.3 |
7.4 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.3 |
0.3 |
GO:0036023 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.3 |
68.4 |
GO:0060271 |
cilium morphogenesis(GO:0060271) |
| 0.3 |
4.0 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.3 |
2.6 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.3 |
1.6 |
GO:1902896 |
terminal web assembly(GO:1902896) |
| 0.3 |
0.3 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.3 |
1.3 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.3 |
0.3 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.3 |
1.3 |
GO:0035900 |
response to isolation stress(GO:0035900) |
| 0.3 |
1.9 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.3 |
0.3 |
GO:0036079 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.3 |
4.8 |
GO:0045008 |
depyrimidination(GO:0045008) |
| 0.3 |
0.3 |
GO:0090325 |
regulation of locomotion involved in locomotory behavior(GO:0090325) |
| 0.3 |
3.5 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.3 |
1.0 |
GO:0045425 |
positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
| 0.3 |
3.2 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.3 |
0.9 |
GO:0003183 |
mitral valve morphogenesis(GO:0003183) |
| 0.3 |
0.6 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.3 |
1.3 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 0.3 |
0.9 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.3 |
1.3 |
GO:0000451 |
rRNA 2'-O-methylation(GO:0000451) |
| 0.3 |
0.9 |
GO:0002371 |
dendritic cell cytokine production(GO:0002371) |
| 0.3 |
3.4 |
GO:0036302 |
atrioventricular canal development(GO:0036302) |
| 0.3 |
2.8 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.3 |
2.5 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.3 |
1.9 |
GO:0046092 |
deoxycytidine metabolic process(GO:0046092) |
| 0.3 |
0.3 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.3 |
8.0 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.3 |
0.3 |
GO:0046619 |
optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.3 |
25.2 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.3 |
0.9 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.3 |
1.2 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.3 |
1.2 |
GO:0006531 |
aspartate metabolic process(GO:0006531) |
| 0.3 |
1.5 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.3 |
3.0 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.3 |
0.9 |
GO:0075713 |
establishment of integrated proviral latency(GO:0075713) |
| 0.3 |
1.2 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.3 |
1.8 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.3 |
3.3 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.3 |
2.1 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
| 0.3 |
1.8 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.3 |
0.9 |
GO:0002589 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.3 |
5.4 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.3 |
0.3 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.3 |
0.6 |
GO:0090069 |
regulation of ribosome biogenesis(GO:0090069) regulation of rRNA processing(GO:2000232) |
| 0.3 |
3.6 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.3 |
1.8 |
GO:0042822 |
pyridoxal phosphate metabolic process(GO:0042822) |
| 0.3 |
0.6 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 0.3 |
2.7 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.3 |
2.7 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.3 |
1.8 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.3 |
0.3 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 0.3 |
1.2 |
GO:0015744 |
succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.3 |
1.8 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.3 |
0.9 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.3 |
0.9 |
GO:1903899 |
positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.3 |
2.0 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.3 |
2.6 |
GO:0015870 |
acetylcholine transport(GO:0015870) |
| 0.3 |
5.2 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.3 |
3.2 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.3 |
0.9 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.3 |
1.2 |
GO:0039506 |
modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 0.3 |
0.9 |
GO:0036111 |
very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.3 |
0.3 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.3 |
1.1 |
GO:1990036 |
regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) calcium ion import into sarcoplasmic reticulum(GO:1990036) |
| 0.3 |
0.9 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.3 |
0.6 |
GO:1903352 |
L-ornithine transmembrane transport(GO:1903352) |
| 0.3 |
1.1 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.3 |
1.4 |
GO:0017062 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.3 |
0.3 |
GO:1900225 |
regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
| 0.3 |
1.4 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.3 |
0.3 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.3 |
0.3 |
GO:0007231 |
osmosensory signaling pathway(GO:0007231) |
| 0.3 |
0.6 |
GO:0052314 |
phytoalexin metabolic process(GO:0052314) |
| 0.3 |
1.4 |
GO:2000521 |
negative regulation of immunological synapse formation(GO:2000521) |
| 0.3 |
1.1 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.3 |
1.7 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.3 |
0.8 |
GO:0010730 |
negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.3 |
1.4 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.3 |
1.7 |
GO:0070092 |
regulation of glucagon secretion(GO:0070092) |
| 0.3 |
3.6 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.3 |
0.8 |
GO:0060449 |
bud elongation involved in lung branching(GO:0060449) |
| 0.3 |
0.8 |
GO:0090176 |
microtubule cytoskeleton organization involved in establishment of planar polarity(GO:0090176) |
| 0.3 |
0.3 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.3 |
3.3 |
GO:0015866 |
ADP transport(GO:0015866) |
| 0.3 |
0.8 |
GO:0000967 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.3 |
0.8 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.3 |
0.8 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.3 |
0.8 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.3 |
3.8 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.3 |
5.2 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.3 |
1.4 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.3 |
0.5 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 0.3 |
0.3 |
GO:0014034 |
neural crest cell fate commitment(GO:0014034) |
| 0.3 |
3.0 |
GO:0019317 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.3 |
0.5 |
GO:0060086 |
circadian temperature homeostasis(GO:0060086) |
| 0.3 |
0.5 |
GO:1904732 |
regulation of electron carrier activity(GO:1904732) |
| 0.3 |
1.1 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.3 |
2.4 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.3 |
0.8 |
GO:0070901 |
mitochondrial tRNA methylation(GO:0070901) |
| 0.3 |
6.9 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.3 |
0.5 |
GO:0035712 |
T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.3 |
4.0 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.3 |
1.1 |
GO:1904588 |
cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.3 |
2.9 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.3 |
0.3 |
GO:1902908 |
regulation of melanosome transport(GO:1902908) |
| 0.3 |
0.5 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) |
| 0.3 |
1.6 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.3 |
0.8 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.3 |
2.3 |
GO:1903142 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.3 |
2.3 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.3 |
1.3 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.3 |
0.5 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.3 |
5.5 |
GO:0050962 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.3 |
10.4 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.3 |
1.0 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.3 |
1.6 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.3 |
3.4 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.3 |
2.6 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.3 |
0.3 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.3 |
3.6 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.3 |
0.5 |
GO:1904049 |
negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.3 |
1.0 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.3 |
1.8 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.3 |
0.8 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.3 |
0.3 |
GO:0006293 |
nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.3 |
1.0 |
GO:0034628 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.3 |
0.8 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.3 |
0.5 |
GO:0035947 |
regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
| 0.3 |
1.8 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.3 |
0.3 |
GO:0072053 |
renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.3 |
1.0 |
GO:0090290 |
positive regulation of osteoclast proliferation(GO:0090290) |
| 0.3 |
0.8 |
GO:0018160 |
peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 0.3 |
0.3 |
GO:0039019 |
pronephric nephron development(GO:0039019) pronephric nephron tubule development(GO:0039020) |
| 0.2 |
1.5 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.2 |
7.7 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.2 |
0.5 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.2 |
0.2 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 |
2.2 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.2 |
2.0 |
GO:0072310 |
glomerular epithelial cell development(GO:0072310) |
| 0.2 |
1.5 |
GO:0098902 |
regulation of membrane depolarization during action potential(GO:0098902) |
| 0.2 |
14.2 |
GO:0001510 |
RNA methylation(GO:0001510) |
| 0.2 |
1.7 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.2 |
3.4 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.2 |
0.7 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 |
0.2 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.2 |
5.3 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.2 |
4.3 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.2 |
0.2 |
GO:2000520 |
regulation of immunological synapse formation(GO:2000520) |
| 0.2 |
2.2 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.2 |
2.6 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.2 |
1.9 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 |
1.0 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.2 |
4.5 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.2 |
0.2 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.2 |
0.5 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.2 |
0.5 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.2 |
0.2 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.2 |
1.4 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.2 |
1.2 |
GO:0009138 |
pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.2 |
0.5 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.2 |
0.2 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.2 |
0.5 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.2 |
4.2 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.2 |
1.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.2 |
0.5 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.2 |
12.9 |
GO:0021795 |
cerebral cortex cell migration(GO:0021795) |
| 0.2 |
0.7 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.2 |
0.9 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.2 |
1.8 |
GO:0097052 |
L-kynurenine metabolic process(GO:0097052) |
| 0.2 |
0.7 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.2 |
0.7 |
GO:0097012 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.2 |
3.0 |
GO:0060765 |
regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.2 |
0.2 |
GO:0033625 |
positive regulation of integrin activation(GO:0033625) |
| 0.2 |
0.7 |
GO:0038043 |
interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.2 |
0.5 |
GO:0035261 |
external genitalia morphogenesis(GO:0035261) |
| 0.2 |
0.9 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.2 |
1.3 |
GO:0035549 |
positive regulation of interferon-beta secretion(GO:0035549) |
| 0.2 |
2.2 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.2 |
1.3 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.2 |
1.3 |
GO:0006574 |
valine catabolic process(GO:0006574) |
| 0.2 |
3.1 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 |
3.6 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 |
1.6 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.2 |
0.2 |
GO:1903401 |
L-lysine transmembrane transport(GO:1903401) |
| 0.2 |
0.2 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 |
0.4 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 |
0.2 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.2 |
12.2 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.2 |
0.7 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 0.2 |
1.1 |
GO:1902559 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.2 |
0.7 |
GO:0072711 |
response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
| 0.2 |
0.7 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.2 |
2.4 |
GO:1902221 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.2 |
0.4 |
GO:0006711 |
estrogen catabolic process(GO:0006711) |
| 0.2 |
0.6 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.2 |
0.4 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.2 |
2.1 |
GO:0015682 |
ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
| 0.2 |
18.7 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 |
0.4 |
GO:0006286 |
base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
| 0.2 |
2.1 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.2 |
0.8 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.2 |
0.4 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.2 |
0.6 |
GO:0035983 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.2 |
1.9 |
GO:0072348 |
sulfur compound transport(GO:0072348) |
| 0.2 |
0.8 |
GO:0010269 |
response to selenium ion(GO:0010269) |
| 0.2 |
0.8 |
GO:0099624 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.2 |
2.3 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 |
2.3 |
GO:0060916 |
mesenchymal cell proliferation involved in lung development(GO:0060916) |
| 0.2 |
3.9 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.2 |
2.1 |
GO:0021903 |
rostrocaudal neural tube patterning(GO:0021903) |
| 0.2 |
1.6 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.2 |
3.7 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.2 |
1.2 |
GO:0001710 |
mesodermal cell fate commitment(GO:0001710) |
| 0.2 |
0.6 |
GO:0008628 |
hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.2 |
0.2 |
GO:0034085 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 |
3.3 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.2 |
0.6 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.2 |
1.0 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.2 |
2.7 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 |
1.6 |
GO:0009304 |
tRNA transcription(GO:0009304) |
| 0.2 |
6.1 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.2 |
1.6 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.2 |
1.6 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.2 |
0.8 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.2 |
1.2 |
GO:0060406 |
positive regulation of penile erection(GO:0060406) |
| 0.2 |
0.6 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 |
1.8 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.2 |
0.6 |
GO:0061010 |
gall bladder development(GO:0061010) hepatic duct development(GO:0061011) |
| 0.2 |
1.0 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.2 |
1.0 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.2 |
1.0 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.2 |
0.8 |
GO:0097210 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.2 |
2.0 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.2 |
0.8 |
GO:1904327 |
protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.2 |
1.2 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.2 |
1.8 |
GO:2000757 |
negative regulation of peptidyl-lysine acetylation(GO:2000757) |
| 0.2 |
2.3 |
GO:0031441 |
negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.2 |
0.4 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.2 |
0.4 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.2 |
1.5 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) |
| 0.2 |
0.8 |
GO:2001200 |
positive regulation of dendritic cell differentiation(GO:2001200) |
| 0.2 |
2.3 |
GO:2000095 |
regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.2 |
1.9 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.2 |
1.0 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.2 |
0.4 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.2 |
1.7 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 |
0.2 |
GO:0061740 |
protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
| 0.2 |
2.7 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.2 |
0.8 |
GO:1905206 |
positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
| 0.2 |
0.8 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.2 |
0.4 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.2 |
1.7 |
GO:0034138 |
toll-like receptor 3 signaling pathway(GO:0034138) |
| 0.2 |
2.4 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.2 |
1.7 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.2 |
0.9 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.2 |
2.2 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.2 |
12.6 |
GO:0002220 |
innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
| 0.2 |
0.7 |
GO:1904479 |
negative regulation of intestinal absorption(GO:1904479) |
| 0.2 |
0.9 |
GO:0001714 |
endodermal cell fate specification(GO:0001714) |
| 0.2 |
0.2 |
GO:2000405 |
negative regulation of T cell migration(GO:2000405) |
| 0.2 |
1.5 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.2 |
0.4 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.2 |
0.5 |
GO:1904247 |
regulation of polynucleotide adenylyltransferase activity(GO:1904245) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.2 |
0.9 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.2 |
0.4 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.2 |
0.5 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
1.3 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.2 |
0.7 |
GO:0032225 |
regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.2 |
0.7 |
GO:0009305 |
protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
| 0.2 |
1.1 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.2 |
0.9 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.2 |
2.5 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.2 |
0.2 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.2 |
2.5 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.2 |
0.3 |
GO:0019541 |
propionate metabolic process(GO:0019541) |
| 0.2 |
0.2 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.2 |
1.0 |
GO:0034134 |
toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.2 |
0.9 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 |
0.3 |
GO:0009624 |
response to nematode(GO:0009624) |
| 0.2 |
0.7 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.2 |
1.5 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.2 |
14.7 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.2 |
1.0 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.2 |
0.7 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.2 |
1.0 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.2 |
1.9 |
GO:0070862 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 |
4.1 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.2 |
0.7 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.2 |
0.3 |
GO:1904528 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.2 |
3.9 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.2 |
0.5 |
GO:0015842 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.2 |
0.8 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.2 |
0.5 |
GO:0052422 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.2 |
1.8 |
GO:0003374 |
dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.2 |
0.5 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.2 |
2.0 |
GO:0014854 |
response to inactivity(GO:0014854) |
| 0.2 |
3.2 |
GO:2001046 |
positive regulation of integrin-mediated signaling pathway(GO:2001046) |
| 0.2 |
0.5 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.2 |
0.3 |
GO:0061355 |
Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.2 |
2.8 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 |
8.9 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.2 |
1.3 |
GO:0060368 |
regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.2 |
0.8 |
GO:2001295 |
malonyl-CoA biosynthetic process(GO:2001295) |
| 0.2 |
2.3 |
GO:0060412 |
ventricular septum morphogenesis(GO:0060412) |
| 0.2 |
0.5 |
GO:1903381 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.2 |
1.0 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.2 |
0.3 |
GO:1901858 |
regulation of mitochondrial DNA metabolic process(GO:1901858) |
| 0.2 |
0.5 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.2 |
1.1 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.2 |
3.9 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.2 |
0.6 |
GO:2000773 |
negative regulation of cellular senescence(GO:2000773) |
| 0.2 |
1.1 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.2 |
1.0 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.2 |
2.9 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.2 |
0.3 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.2 |
2.1 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.2 |
0.3 |
GO:0001878 |
response to yeast(GO:0001878) |
| 0.2 |
0.8 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.2 |
0.5 |
GO:0090222 |
centrosome-templated microtubule nucleation(GO:0090222) |
| 0.2 |
0.5 |
GO:0046056 |
dADP metabolic process(GO:0046056) |
| 0.2 |
0.6 |
GO:0042416 |
dopamine biosynthetic process(GO:0042416) |
| 0.2 |
0.9 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.2 |
0.3 |
GO:0090027 |
negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.2 |
0.8 |
GO:1902267 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.2 |
0.2 |
GO:0045342 |
MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.2 |
1.4 |
GO:0010960 |
magnesium ion homeostasis(GO:0010960) |
| 0.2 |
0.2 |
GO:1901374 |
acetate ester transport(GO:1901374) |
| 0.2 |
1.4 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.2 |
2.6 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.2 |
0.8 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.2 |
4.1 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.2 |
1.5 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.1 |
1.6 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.1 |
GO:0032071 |
regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.1 |
2.4 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.1 |
1.0 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
0.7 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.1 |
0.1 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 0.1 |
4.9 |
GO:0042026 |
protein refolding(GO:0042026) |
| 0.1 |
0.1 |
GO:0046016 |
positive regulation of transcription by glucose(GO:0046016) |
| 0.1 |
0.4 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.1 |
0.3 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.1 |
1.0 |
GO:0043967 |
histone H4 acetylation(GO:0043967) |
| 0.1 |
1.2 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.1 |
0.6 |
GO:0098957 |
anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.1 |
2.4 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 |
4.3 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.1 |
0.1 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.1 |
0.3 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 |
2.1 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 |
1.0 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 |
0.6 |
GO:0055062 |
phosphate ion homeostasis(GO:0055062) trivalent inorganic anion homeostasis(GO:0072506) |
| 0.1 |
0.3 |
GO:0048560 |
establishment of anatomical structure orientation(GO:0048560) |
| 0.1 |
0.6 |
GO:1904045 |
cellular response to aldosterone(GO:1904045) |
| 0.1 |
0.1 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.1 |
0.3 |
GO:2000118 |
regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.1 |
0.3 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.1 |
0.1 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 |
2.5 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.1 |
0.7 |
GO:0043126 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.1 |
3.4 |
GO:0021952 |
central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.1 |
0.8 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.1 |
3.8 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
3.0 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.7 |
GO:0002357 |
defense response to tumor cell(GO:0002357) |
| 0.1 |
1.1 |
GO:0060235 |
lens induction in camera-type eye(GO:0060235) |
| 0.1 |
0.5 |
GO:0010044 |
response to aluminum ion(GO:0010044) |
| 0.1 |
6.2 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.1 |
0.5 |
GO:1900094 |
determination of left/right asymmetry in lateral mesoderm(GO:0003140) nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
| 0.1 |
0.8 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.3 |
GO:1900226 |
negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.1 |
0.9 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
0.3 |
GO:0034285 |
response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.1 |
0.5 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.1 |
0.5 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.1 |
0.5 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 |
0.8 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.1 |
2.1 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.1 |
0.9 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 0.1 |
0.6 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.1 |
0.1 |
GO:0071926 |
endocannabinoid signaling pathway(GO:0071926) |
| 0.1 |
0.3 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.1 |
1.7 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 |
0.5 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 |
0.5 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.1 |
2.1 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 |
0.5 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.1 |
0.4 |
GO:1904383 |
response to sodium phosphate(GO:1904383) |
| 0.1 |
1.1 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 |
0.5 |
GO:0052651 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.1 |
0.1 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 |
1.0 |
GO:0043555 |
regulation of translation in response to stress(GO:0043555) |
| 0.1 |
0.4 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.1 |
0.1 |
GO:2001301 |
lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.1 |
0.4 |
GO:0044278 |
cell wall disruption in other organism(GO:0044278) |
| 0.1 |
1.0 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.1 |
0.2 |
GO:0003064 |
regulation of heart rate by hormone(GO:0003064) |
| 0.1 |
0.2 |
GO:0051344 |
negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 |
0.5 |
GO:0007207 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.1 |
0.2 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.1 |
10.2 |
GO:0031295 |
T cell costimulation(GO:0031295) |
| 0.1 |
1.4 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 |
1.2 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.1 |
1.2 |
GO:0043981 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 |
0.5 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.1 |
0.6 |
GO:1902659 |
regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.1 |
3.2 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 |
4.9 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.1 |
1.1 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.1 |
0.4 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 |
0.4 |
GO:1903598 |
positive regulation of gap junction assembly(GO:1903598) |
| 0.1 |
0.4 |
GO:0060982 |
coronary artery morphogenesis(GO:0060982) |
| 0.1 |
2.6 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.1 |
0.3 |
GO:0046116 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
3.6 |
GO:1900739 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.1 |
0.5 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 |
0.8 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.1 |
1.4 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 |
0.5 |
GO:1903588 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.1 |
2.6 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.1 |
0.3 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.1 |
0.6 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.1 |
1.6 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 |
0.7 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.1 |
1.0 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 0.1 |
0.3 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.1 |
0.8 |
GO:0032239 |
regulation of nucleobase-containing compound transport(GO:0032239) |
| 0.1 |
1.2 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 |
2.4 |
GO:0071431 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 |
0.3 |
GO:0009085 |
lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
| 0.1 |
0.4 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.1 |
0.1 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.1 |
1.3 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
| 0.1 |
0.1 |
GO:0051030 |
snRNA export from nucleus(GO:0006408) snRNA transport(GO:0051030) |
| 0.1 |
0.8 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.1 |
0.5 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.1 |
0.3 |
GO:0046247 |
tetraterpenoid metabolic process(GO:0016108) carotenoid metabolic process(GO:0016116) carotene catabolic process(GO:0016121) xanthophyll metabolic process(GO:0016122) terpene catabolic process(GO:0046247) |
| 0.1 |
1.0 |
GO:0070202 |
regulation of establishment of protein localization to chromosome(GO:0070202) |
| 0.1 |
3.4 |
GO:0000726 |
non-recombinational repair(GO:0000726) |
| 0.1 |
0.9 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 |
0.9 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 |
1.0 |
GO:0086024 |
adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.1 |
0.3 |
GO:1903595 |
positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.1 |
0.8 |
GO:1902914 |
regulation of protein polyubiquitination(GO:1902914) |
| 0.1 |
0.5 |
GO:0050428 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.1 |
0.2 |
GO:0019184 |
nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.1 |
0.4 |
GO:0010902 |
positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.1 |
0.3 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.1 |
0.3 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.1 |
10.9 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.1 |
0.5 |
GO:0034959 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 |
0.2 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.1 |
2.9 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.1 |
0.1 |
GO:0002434 |
immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) |
| 0.1 |
0.1 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.1 |
0.3 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.8 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 |
1.1 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.1 |
0.3 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
0.1 |
GO:0018283 |
metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.1 |
0.3 |
GO:0070424 |
regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.1 |
0.3 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.1 |
0.4 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.1 |
0.1 |
GO:0048682 |
axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
| 0.1 |
0.1 |
GO:0051389 |
inactivation of MAPKK activity(GO:0051389) |
| 0.1 |
0.4 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
3.0 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.2 |
GO:0070525 |
tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.1 |
0.6 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.1 |
0.3 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
1.6 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.1 |
0.5 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.1 |
0.1 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 |
1.6 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.1 |
0.4 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.1 |
1.1 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.6 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
2.0 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.1 |
0.3 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.1 |
0.3 |
GO:2000174 |
regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.1 |
0.5 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.1 |
0.4 |
GO:0093001 |
glycolytic process through glucose-1-phosphate(GO:0061622) glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.1 |
2.0 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.1 |
0.8 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.1 |
0.1 |
GO:0060018 |
astrocyte fate commitment(GO:0060018) |
| 0.1 |
0.6 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 |
0.4 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 |
0.1 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.1 |
1.1 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
0.7 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.2 |
GO:0042090 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.9 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
0.1 |
GO:1904139 |
microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
| 0.1 |
0.3 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) |
| 0.1 |
4.2 |
GO:0046839 |
phospholipid dephosphorylation(GO:0046839) |
| 0.1 |
1.7 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
3.2 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.1 |
0.3 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.1 |
0.2 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.1 |
0.1 |
GO:0006505 |
GPI anchor metabolic process(GO:0006505) |
| 0.1 |
0.4 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.2 |
GO:0043321 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.1 |
0.1 |
GO:0072106 |
regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.1 |
0.3 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.1 |
1.9 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.1 |
2.5 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
| 0.1 |
0.6 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 |
0.5 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.1 |
0.5 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.1 |
0.8 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 |
0.4 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.1 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.1 |
0.2 |
GO:0034443 |
regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.1 |
0.2 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 |
0.2 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
0.3 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.1 |
3.7 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 |
0.1 |
GO:0090133 |
mesendoderm migration(GO:0090133) cell migration involved in mesendoderm migration(GO:0090134) |
| 0.1 |
3.5 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.1 |
0.3 |
GO:0002320 |
lymphoid progenitor cell differentiation(GO:0002320) |
| 0.1 |
0.3 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.1 |
0.3 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.1 |
0.1 |
GO:0061152 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.1 |
0.1 |
GO:0019376 |
galactolipid catabolic process(GO:0019376) |
| 0.1 |
0.5 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.1 |
0.4 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.1 |
0.1 |
GO:0002606 |
positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.1 |
9.2 |
GO:0007286 |
spermatid development(GO:0007286) |
| 0.1 |
2.7 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.1 |
0.3 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
| 0.1 |
1.8 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
0.8 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.1 |
0.1 |
GO:0021834 |
chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) dorsal/ventral axon guidance(GO:0033563) |
| 0.1 |
0.1 |
GO:0060285 |
cilium-dependent cell motility(GO:0060285) |
| 0.1 |
0.4 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.1 |
0.6 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.1 |
0.1 |
GO:0099563 |
modification of synaptic structure(GO:0099563) |
| 0.1 |
0.3 |
GO:0052312 |
positive regulation by host of viral transcription(GO:0043923) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) |
| 0.1 |
0.7 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 |
0.2 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
0.1 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.1 |
0.2 |
GO:1901299 |
negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
| 0.1 |
1.0 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 |
0.2 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.1 |
1.1 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.1 |
0.5 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.1 |
1.4 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 |
0.5 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
0.3 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.1 |
0.3 |
GO:0033145 |
positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
| 0.1 |
0.2 |
GO:0061580 |
colon epithelial cell migration(GO:0061580) |
| 0.1 |
0.1 |
GO:1904397 |
negative regulation of neuromuscular junction development(GO:1904397) |
| 0.1 |
1.0 |
GO:0031498 |
chromatin disassembly(GO:0031498) |
| 0.1 |
0.6 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 |
0.3 |
GO:0032324 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.1 |
0.5 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.1 |
2.2 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 |
0.1 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 |
0.2 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.1 |
0.2 |
GO:0050992 |
dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.1 |
0.1 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.1 |
0.7 |
GO:0031282 |
regulation of guanylate cyclase activity(GO:0031282) |
| 0.1 |
0.1 |
GO:0090191 |
negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.1 |
0.1 |
GO:0002305 |
gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.1 |
0.2 |
GO:1904021 |
negative regulation of G-protein coupled receptor internalization(GO:1904021) |
| 0.1 |
0.1 |
GO:0010159 |
specification of organ position(GO:0010159) |
| 0.0 |
0.0 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 |
1.3 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.0 |
0.6 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.0 |
0.2 |
GO:0018027 |
peptidyl-lysine dimethylation(GO:0018027) |
| 0.0 |
0.1 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.0 |
0.0 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.0 |
0.9 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.0 |
0.4 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.0 |
0.5 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 |
0.2 |
GO:0007549 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 |
0.2 |
GO:0034499 |
late endosome to Golgi transport(GO:0034499) |
| 0.0 |
0.3 |
GO:0048296 |
regulation of isotype switching to IgA isotypes(GO:0048296) |
| 0.0 |
0.3 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.0 |
0.2 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.0 |
0.4 |
GO:0006896 |
Golgi to vacuole transport(GO:0006896) |
| 0.0 |
0.2 |
GO:2000152 |
regulation of ubiquitin-specific protease activity(GO:2000152) |
| 0.0 |
0.0 |
GO:0002428 |
antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
| 0.0 |
0.0 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.0 |
0.6 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.0 |
0.2 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.0 |
0.7 |
GO:0090022 |
regulation of neutrophil chemotaxis(GO:0090022) |
| 0.0 |
0.2 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) ketone body biosynthetic process(GO:0046951) |
| 0.0 |
1.7 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.0 |
0.2 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.0 |
0.2 |
GO:0031935 |
regulation of chromatin silencing(GO:0031935) |
| 0.0 |
0.0 |
GO:0035771 |
interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.0 |
0.1 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) synaptic growth at neuromuscular junction(GO:0051124) regulation of neuromuscular junction development(GO:1904396) |
| 0.0 |
0.9 |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.0 |
0.0 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.0 |
0.1 |
GO:0010607 |
negative regulation of cytoplasmic mRNA processing body assembly(GO:0010607) |
| 0.0 |
0.3 |
GO:0002638 |
negative regulation of immunoglobulin production(GO:0002638) |
| 0.0 |
0.2 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.0 |
0.1 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.0 |
0.5 |
GO:0035810 |
positive regulation of urine volume(GO:0035810) |
| 0.0 |
0.3 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.0 |
0.1 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.0 |
0.1 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.0 |
0.3 |
GO:0002053 |
positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.0 |
0.1 |
GO:0060335 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.0 |
0.2 |
GO:0001963 |
synaptic transmission, dopaminergic(GO:0001963) |
| 0.0 |
0.1 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.0 |
0.2 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.0 |
0.1 |
GO:0098881 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.0 |
1.0 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
1.6 |
GO:0000725 |
recombinational repair(GO:0000725) |
| 0.0 |
0.4 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
0.3 |
GO:0044346 |
fibroblast apoptotic process(GO:0044346) |
| 0.0 |
3.1 |
GO:0035308 |
negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
| 0.0 |
0.3 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.1 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.0 |
0.3 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.0 |
0.2 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.0 |
0.2 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.0 |
0.1 |
GO:0002023 |
reduction of food intake in response to dietary excess(GO:0002023) |
| 0.0 |
0.5 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
| 0.0 |
0.2 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.5 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.0 |
0.1 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.0 |
0.6 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 |
0.1 |
GO:0043578 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.0 |
0.3 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.0 |
0.0 |
GO:2000576 |
positive regulation of microtubule motor activity(GO:2000576) |
| 0.0 |
0.1 |
GO:0070370 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.0 |
0.0 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.0 |
1.4 |
GO:0071427 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.0 |
0.0 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.0 |
0.4 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.6 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.0 |
0.3 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 |
0.1 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.0 |
0.1 |
GO:0070895 |
transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 0.0 |
0.5 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 |
0.1 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.0 |
0.5 |
GO:0021762 |
substantia nigra development(GO:0021762) |
| 0.0 |
0.1 |
GO:0002933 |
lipid hydroxylation(GO:0002933) |
| 0.0 |
0.1 |
GO:0090063 |
positive regulation of microtubule nucleation(GO:0090063) |
| 0.0 |
3.5 |
GO:0000209 |
protein polyubiquitination(GO:0000209) |
| 0.0 |
0.0 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.0 |
0.1 |
GO:0010578 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.0 |
0.0 |
GO:1903537 |
meiotic spindle elongation(GO:0051232) meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.0 |
0.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.7 |
GO:0006283 |
transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.0 |
0.0 |
GO:0071638 |
negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.0 |
0.1 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.0 |
0.1 |
GO:0032329 |
serine transport(GO:0032329) |
| 0.0 |
0.0 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.0 |
0.2 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.0 |
0.0 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.0 |
0.0 |
GO:0002540 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
